Personal CFO Solutions LLC raised its position in Synopsys, Inc. (NASDAQ:SNPS – Free Report) by 180.8% during the third quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 2,634 shares of the semiconductor company’s stock after buying an additional 1,696 shares during the period. Personal CFO Solutions LLC’s holdings in Synopsys were worth $1,300,000 as of its most recent SEC filing.
A number of other institutional investors also recently modified their holdings of SNPS. Alpine Bank Wealth Management increased its holdings in Synopsys by 89.3% during the 3rd quarter. Alpine Bank Wealth Management now owns 53 shares of the semiconductor company’s stock valued at $26,000 after purchasing an additional 25 shares in the last quarter. TFC Financial Management Inc. lifted its position in Synopsys by 1,250.0% during the 3rd quarter. TFC Financial Management Inc. now owns 54 shares of the semiconductor company’s stock worth $27,000 after buying an additional 50 shares in the last quarter. Millstone Evans Group LLC acquired a new position in Synopsys during the 3rd quarter worth about $27,000. SOA Wealth Advisors LLC. bought a new stake in Synopsys during the 3rd quarter worth about $28,000. Finally, McIlrath & Eck LLC acquired a new stake in Synopsys in the 3rd quarter valued at about $29,000. Institutional investors own 85.47% of the company’s stock.
Synopsys Stock Down 0.6%
Synopsys stock opened at $439.94 on Friday. The firm has a market capitalization of $84.17 billion, a price-to-earnings ratio of 55.06, a PEG ratio of 3.68 and a beta of 1.12. The company’s 50 day simple moving average is $474.06 and its 200 day simple moving average is $483.92. The company has a debt-to-equity ratio of 0.48, a current ratio of 1.62 and a quick ratio of 1.52. Synopsys, Inc. has a fifty-two week low of $365.74 and a fifty-two week high of $651.73.
Analyst Ratings Changes
A number of brokerages have weighed in on SNPS. HSBC downgraded shares of Synopsys from a “buy” rating to a “hold” rating and set a $455.00 target price for the company. in a research note on Friday. Wall Street Zen raised Synopsys from a “sell” rating to a “hold” rating in a report on Saturday, December 13th. Morgan Stanley upped their price target on Synopsys from $510.00 to $550.00 and gave the company an “overweight” rating in a research note on Friday, December 12th. Wells Fargo & Company lifted their price objective on Synopsys from $445.00 to $500.00 and gave the stock an “equal weight” rating in a research report on Thursday, December 11th. Finally, Citigroup started coverage on shares of Synopsys in a research note on Monday, November 24th. They issued a “buy” rating and a $580.00 target price on the stock. Nine research analysts have rated the stock with a Buy rating, seven have given a Hold rating and one has assigned a Sell rating to the stock. According to data from MarketBeat.com, the company presently has a consensus rating of “Hold” and an average price target of $547.00.
Get Our Latest Research Report on Synopsys
Insider Buying and Selling
In related news, CFO Shelagh Glaser sold 3,657 shares of the business’s stock in a transaction on Friday, December 19th. The shares were sold at an average price of $460.77, for a total value of $1,685,035.89. Following the sale, the chief financial officer directly owned 17,842 shares of the company’s stock, valued at approximately $8,221,058.34. The trade was a 17.01% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. Also, insider Janet Lee sold 250 shares of the company’s stock in a transaction on Monday, January 12th. The stock was sold at an average price of $530.00, for a total transaction of $132,500.00. Following the completion of the transaction, the insider directly owned 11,959 shares of the company’s stock, valued at approximately $6,338,270. The trade was a 2.05% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. In the last ninety days, insiders sold 4,157 shares of company stock worth $1,945,036. Insiders own 0.62% of the company’s stock.
Key Synopsys News
Here are the key news stories impacting Synopsys this week:
- Positive Sentiment: NVIDIA added a large stake in Synopsys (reported ~4.8M shares, >$2.2B at end-Q4), highlighting strategic alignment between SNPS and AI/semiconductor leaders and lending a strong institutional vote of confidence. NVIDIA’s 13F Bombshell: A New AI Power Trio Emerges
- Positive Sentiment: Board refresh: Synopsys appointed former Deloitte executive Peter A. Shimer to the board and expanded the board as part of governance updates — adds deep financial and leadership experience that investors often view as supportive for oversight and capital allocation. Synopsys Appoints Former Deloitte Executive Peter Shimer to Board of Directors and Announces Board Transitions
- Positive Sentiment: Partnership expansion: Synopsys deepened its AI design and security capabilities via a SimuTech partnership, which could broaden product adoption in AI-focused chip design workflows. Synopsys Deepens AI Design And Security Reach With SimuTech Partnership
- Neutral Sentiment: Analysts and earnings watch: Multiple previews (Zacks/Yahoo) flag Q1 results as a near-term catalyst — key metrics vs. guidance will likely drive short-term volatility around the report. Synopsys (SNPS) Q1 Earnings on the Horizon: Analysts’ Insights on Key Performance Measures
- Neutral Sentiment: Mixed investor reaction coverage discusses AI-disruption fears, chiplet competition and the Ansys deal — narrative is mixed and could add noise to sentiment without a single clear directional effect. How Investors Are Reacting To Synopsys (SNPS) AI Disruption Fears Amid Chiplet Push And Ansys Deal
- Negative Sentiment: HSBC downgraded SNPS from Buy to Hold and set a $455 price target, a move that can weigh on sentiment and selling pressure even though the PT still implies modest upside. SNPS: HSBC downgrades
Synopsys Company Profile
Synopsys, Inc is a leading provider of electronic design automation (EDA) software and semiconductor intellectual property (IP) used to design, verify and manufacture integrated circuits and complex systems-on-chip (SoCs). Its product portfolio spans tools and technologies for front‑end design and synthesis, simulation and verification, physical implementation and signoff, and design-for-manufacturability, enabling chip designers to move from architecture through tape‑out.
In addition to core EDA offerings, Synopsys supplies a broad set of semiconductor IP building blocks — such as interface, memory and analog/mixed-signal cores — that customers integrate into SoCs to accelerate development.
See Also
- Five stocks we like better than Synopsys
- The gold chart Wall Street is terrified of…
- Buy this Gold Stock Before May 2026
- What a Former CIA Agent Knows About the Coming Collapse
- This $15 Stock Could Go Down as the #1 Stock of 2026
- New gold price target
Want to see what other hedge funds are holding SNPS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Synopsys, Inc. (NASDAQ:SNPS – Free Report).
Receive News & Ratings for Synopsys Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Synopsys and related companies with MarketBeat.com's FREE daily email newsletter.
